Scroll To Top

gilead

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.

The Real Housewives of Gilead

Meet the women who want to bring us back to the Dark Ages -- or to a future envisioned by Margaret Atwood.

True

FDA Approves Gilead AIDS Drug for Hepatitis B

Gilead Sciences Inc. prepared to expand its reach further beyond AIDS drugs Monday after federal regulators approved the biotech drug maker's signature anti-HIV therapy as a hepatitis B treatment.

PrEP4All Claims Gilead Held Back Safer HIV Drug

The activist group wants the federal government to reject a patent extension for Gilead's tenofovir alafenamide, a component of several HIV meds.

Gilead Gives $4.5 Million to Trans Groups on Day of Remembrance

The pharmaceutical company formed a transgender board of advisers, which guided how to distribute the historic donation.

AOC Grills Gilead CEO on Truvada Cost: 'People Are Dying'

The congresswoman asked why the HIV prevention drug costs nearly $2,000 in the U.S. but only $8 in Australia.

Gilead Will Donate Truvada to 200,000 People Annually for 11 Years

The donation amounts to 2.4 million bottles each year -- but activists say it isn't enough.

Gilead Made $3 Billion Off Truvada Last Year

The U.S. government, which developed and patented the use of Truvada for PrEP, got nothing.

The Women of Gilead Rise Up in The Handmaid's Tale's Second Season

Samira Wiley and Alexis Bledel speak with The Advocate about solidarity, sisterhood, and taking on the patriarchy.